Video

Dr. Cibula on Adding Dendritic Cell-Based Immunotherapy to Chemotherapy in Ovarian Cancer

David Cibula, MD, a gynecologic oncologist at the Gynaecologic Center of Charles University, discusses a trial that examined the addition of dendritic cell-based immunotherapy to chemotherapy in patients with relapsed ovarian cancer.

David Cibula, MD, a gynecologic oncologist at the Gynaecologic Center of Charles University, discusses a trial that examined the addition of dendritic cell-based immunotherapy to chemotherapy in patients with relapsed ovarian cancer.

There is an unmet need to find new treatment modalities in ovarian cancer, explains Cibula. Ovarian cancers have a relatively high mutational burden, which means there will not be a simple monotherapy that will work in this population. Therefore, many investigators are testing various combination therapies to treat patients. Further research may find the combination of dendritic cell-based immunotherapy DCVAC/OvCA and standard carboplatin and gemcitabine among them, adds Cibula.

In the phase II open-label trial, patients with relapsed, platinum-sensitive, epithelial ovarian cancer were randomized 1:1 to receive standard-of-care therapy with or without DCVAC/OvCA. The trial showed a significant improvement in overall survival (OS) with the vaccine. The hazard ratio was 0.38, which translates to a 62% reduction in the risk of death with the approach. At a median follow-up of 36.6 months, the median rates of OS were 35.5 months and 22.1 months in the DCVAC/OvCA arm and chemotherapy-alone arms, respectively.

Related Videos
Consuelo Bertossi, MD
Michael R. Grunwald, MD, FACP
Sundar Jagannath, MBBS
Kevin Kalinsky, MD, MS,
Aaron Gerds, MD
Paolo Tarantino, MD
Chinmay Jani, MD, clinical fellow, Hematology & Oncology, Sylvester Comprehensive Cancer Center at the University of Miami/Jackson Memorial Hospital
Shella Saint Fleur-Lominy, MD, PhD
Benjamin Levy, MD
Nader Sanai, MD, chief, Neurosurgical Oncology, director, Ivy Brain Tumor Center, Barrow Neurological Institute